Kidney International Supplements

Kidney International Supplements is a peer-reviewed journal published by Elsevier on behalf of the International Society of Nephrology since 2011 under the ISSN 2157-1724 and eISSN 2157-1716, covering nephrology supplements with a 2025 Journal Impact Factor of 8.3 and a first quartile rank of 9 of 134 in urology and nephrology in the Science Citation Index Expanded《肾脏国际补充》（Kidney International Supplements）是（Elsevier）代表国际肾脏学会自 2011 年起出版的同行评审期刊，刊号 2157-1724、电子刊号 2157-1716，覆盖肾脏病学补充内容，2025 年影响因子为 8.3，在（SCIE）泌尿学与肾脏病学类 134 种期刊中列第 9 位、居第一四分位。

Scope

• The journal publishes supplements to Kidney International, including clinical practice guidelines, consensus statements, conference proceedings, systematic reviews and special reports on nephrology该刊刊载《肾脏国际》的补充内容，包括临床实践指南、共识声明、会议论文集、系统综述与肾脏病学专题报告。
• It gives particular attention to evidence-based guidelines and consensus documents developed by nephrology societies and working groups, and it serves as a venue for extended content that complements the parent Kidney International title该刊特别关注由肾脏病学会与工作组制定循证指南与共识文件，并作为补充母刊《肾脏国际》的扩展内容平台。
• Article types include guideline articles, consensus statements, review articles, conference supplements and special reports, and the journal publishes issues in volumes with multiple issues per year文章类型包括指南文章、共识声明、综述、会议补充与专题报告，该刊以卷期出版，每年多期。
• The journal operates a hybrid open access model in which authors may choose to publish under a subscription model or pay an article processing charge for open access under a Creative Commons licence该刊采用混合开放获取模式，作者可选择订阅模式出版，或支付文章处理费以知识共享许可开放获取。
• Peer review is conducted single-blind and the journal follows the Elsevier and International Society of Nephrology editorial policies on data availability, research integrity and competing interests同行评审采用单盲方式，该刊遵循（Elsevier）与国际肾脏学会关于数据可获取性、研究诚信与利益冲突的编辑政策。
• The journal is abstracted and indexed in the Science Citation Index Expanded, Scopus, PubMed, MEDLINE and Chemical Abstracts Service, and it is included in the Journal Citation Reports该刊被（SCIE）、（Scopus）、（PubMed）、（MEDLINE）与（Chemical Abstracts Service）收录，并纳入期刊引证报告。

History

• The journal was launched in 2011 by Elsevier as a companion to Kidney International, the flagship journal of the International Society of Nephrology founded in 1972, to provide a dedicated venue for supplements and extended content该刊于 2011 年由（Elsevier）创办，作为国际肾脏学会 1972 年创办的旗舰刊《肾脏国际》的姊妹刊，为补充内容与扩展材料提供专门平台。
• It was conceived to separate guideline and supplement content from the regular research articles in the parent title, allowing Kidney International to focus on original research while the Supplements title carried extended documents该刊定位为将指南与补充内容从母刊常规研究论文中分离，使《肾脏国际》聚焦原创研究，而补充刊承载扩展文件。
• The journal has published key nephrology guidelines and consensus documents, including KDIGO clinical practice guidelines on chronic kidney disease, dialysis and transplantation management该刊刊载了肾脏病学重要指南与共识文件，包括（KDIGO）关于慢性肾脏病、透析与移植管理的临床实践指南。
• The Journal Impact Factor has shown notable variation, from 10.545 in 2021 to 6.083 in 2022, then 89.6 in 2024 and 8.3 in 2025, reflecting the supplement-driven citation pattern of the title该刊影响因子波动显著，由 2021 年的 10.545 降至 2022 年的 6.083，再升至 2024 年的 89.6 与 2025 年的 8.3，反映该刊以补充内容驱动的引用模式。
• The publisher carries the journal on the ScienceDirect platform and the digital object identifier prefix of its articles is 10.1016, shared with other Elsevier nephrology and medicine journals出版方将该刊载于（ScienceDirect）平台，其文章的数字对象唯一标识符前缀为（10.1016），与（Elsevier）其他肾脏病学与医学期刊一致。

Editors

• The journal is led by an editor-in-chief supported by an international editorial board whose members are drawn from nephrology departments, clinical research institutes and guideline working groups across the world该刊由一位主编带领，配以由世界各地肾脏病科、临床研究机构与指南工作组学者组成的国际编委会。
• The editorial board includes section editors responsible for subject areas such as clinical guidelines, consensus statements, dialysis and transplantation, reflecting the supplement focus of the journal编委会设有学科编辑，分别负责临床指南、共识声明、透析与移植等方向，对应刊物的补充定位。
• Editorial handling follows the Elsevier editorial management system, with submissions assigned to handling editors based on subject expertise and competing interest declarations稿件处理依托（Elsevier）的编辑管理系统，依据学科专长与利益冲突声明分配责任编辑。
• Peer review is conducted single-blind and the journal maintains the International Society of Nephrology standards on reviewer recruitment, conflict of interest management, data sharing and editorial independence同行评审采用单盲方式，该刊遵循国际肾脏学会在审稿人遴选、利益冲突管理、数据共享与编辑独立性方面的标准。
• The masthead and board roster are published on the journal page at ScienceDirect and updated as new members join or existing members step down编委名单在（ScienceDirect）期刊页公布，并随成员增减而更新。